Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

Back to Item »

CHMP Says AMT’s Lipoprotein Lipase Deficiency Candidate Can’t Yet Be Approved

Company hopes new data from patients already treated using Glybera will be sufficient to reverse CHMP opinion.

Forward this item to a colleague:


 
   

(Separate multiple addresses by commas)

   

(Separate multiple addresses by commas)

Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »